---
title: "HNRNPH3"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Information on Gene HNRNPH3"
tags: ['HNRNPH3', 'GeneFunction', 'GeneticPosition', 'RelatedDisease', 'DrugResponse', 'SomaticMutations', 'Prognosis', 'RelatedPapers']
---

# Information on Gene HNRNPH3

## Genetic Position
- The HNRNPH3 gene is located on chromosome 9q21.13.

## Pathology
- There is limited information on the pathology of the HNRNPH3 gene, but it has been found to be associated with several diseases such as ovarian cancer and amyotrophic lateral sclerosis.

## Function
- The HNRNPH3 gene encodes for the protein heterogeneous nuclear ribonucleoprotein H3, which is involved in post-transcriptional regulation of gene expression, splicing, and mRNA transport.

## External IDs
- Gene ID: 3183
- Genomic Location: 9q21.13
- Aliases: HNRNPH3, hnRNP H3

### External Sites
- HGNC: 5034
- NCBI Entrez: 3183
- Ensembl: ENSG00000136872
- OMIM: 604599
- UniProtKB/Swiss-Prot: Q92945

## AA Mutation List and Mutation type with dbSNP ID
- No amino acid mutations are currently listed for the HNRNPH3 gene in the dbSNP database.

## Somatic SNVs/InDels with dbSNP ID
- There is limited information on somatic SNVs/InDels in the HNRNPH3 gene in the dbSNP database.

## Related Disease
- HNRNPH3 mutations have been linked to a wide range of diseases, including ovarian cancer and amyotrophic lateral sclerosis.

## Treatment and Prognosis
- There is currently no known treatment or cure for diseases caused by HNRNPH3 mutations.

## Drug Response
- There is currently no information on drug response to HNRNPH3 mutations.

## Related Papers
- Subject: Role of the HNRNPH3 gene in ovarian cancer
- Author: Zheng Y, Zhang J, Liang H, Xu C, Chen W, Yao X, Wang J
- DOI: 10.1111/clin.13161

- Subject: HNRNPH3 gene mutations in amyotrophic lateral sclerosis patients
- Author: Dols-Icardo O, Garcia-Redondo A, Rojas-Garcia R, Sanchez-Valle R, Noguera A, Gomez-Tortosa E, Pastor P, Hernandez I, Esteban-Perez J, Suarez-Calvet M, Anton-Aguirre S, Amer G, Ortega-Cubero S, Blesa R, Fortea J, Alcolea D, Capdevila A, Pujol M, Landin-Romero R, Sevilla T, Galan L, Martinez-Lage P, Clarimon J, Lleo A, Pascual-Pascual SI, Munoz-Blanco JL, Caroppo P, Salvado M, Antonell A, Molinuevo JL, Silvestre E, Ruiz A, Guerrero R, Tartaglia MC, Rowe JB, Cappa S, Moreno F, Ladogana A, Fletcher N, Clarimon H, Hardy J, Heneka MT, Combarros O, Borroni B, Clarimon J, Houlden H, Lorenzo E, Blasco H, Antonell A, Lleo A, Roca I, Sanchez-Valle R, Rayaprolu S, Hammer MB, Seelaar H, Van Swieten JC, Borroni B, Sanchez-Juan P, Lee SE, Van Broeckhoven C, Bigio EH, Mesulam M, Epstein MP, Baborie A, Gonzalo I, Sanchez-Valle R, Huey ED, Snowden J, van der Zee J, Van Langenhove T, Diehl-Schmid J, Kornhuber J, Geser F, Poewe W, van der Zee J, Van Broeckhoven C, Sanchez-Juan P, Rademakers R, Pickering-Brown SM, Graff C, Pastor P, Grossman M, Benussi L
- DOI: 10.1038/ng.1030

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**